Restore and protect coverage choice among FDAapproved GLP1 medications within FEHB plans
Rocio Salas-Whalen previously told Insider
Semaglutide is recommended for adults who have a body mass index (BMI) of 30 kg/m or greater (obese), or for those with a BMI of 27 kg/m or greater who also have at least one weight-related health condition such as high blood pressure, type 2 diabetes, or high cholesterol
And scientific evidence points to some health benefits, as well
Retatrutide appears more aggressive mechanistically because it activates three receptor pathways
Metabolic and biochemical screening : HbA1c, fasting glucose, lipid profile, liver function tests, renal function, and thyroid function